当前位置: 首页 > 期刊 > 《中国医学创新》 > 2011年第28期
编号:13186754
转化生长因子-α及β与肝再生关系研究进展(3)
http://www.100md.com 2011年10月5日 《中国医学创新》 2011年第28期
     [19] 邓新宇,李文瑞,孙言伟,等.肝再生.世界科技研究与发展,2006,28(6):1-8.

    [20] Kon iaris LG,McKillop IH, Schwartz SI,et al.Liver regeneration.J Am Coll Surg,2003,197(4):634-659.

    [21] Miwa Y,Harrison PM,Farzaneh F,et al.Plasma levels and hepatic mRNA expression of transforming growth factor betal in patients with fulminan thepatic failure.J Hepatol,1997,27(5):780-788.

    [22] Kiba T,Saito S,Numata K,et al.Fas (APO-1/CD95) mR-NA is down-regulated in liver regeneration after hepatec-tomy inrats.Gastroenterol,2000,35(1):34-38.

    [23] Fausto N.Liver regeneration:from laboratory to clinic. Liver Transpl,2001,7(10):835-844.

    [24] Fausto N,Riehle KJ.Mechanisms of liver regeneration and their clinical implications.JH epatobiliary Pancreat Surg,2005,12(3):181-189.

    [25] Thenappan A,Li Y,Kitisin K,et al.Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver.Hepatology,2010,51:1373-1382.

    [26] Sato M,Suzuki S,Senoo H.Hepatic stellate cells:unique characteristics in cell biology and phenotype.Cell Struct Funct,2003,28:105-112.

    [27] 林世德,李玮,龙骏,等.重型肝炎肝再生障碍的相关因素.中华肝脏病杂志,2008,16(10):796-798.

    (收稿日期:2011-06-24)

    (本文编辑:郎威), 百拇医药(丁绍忠 房淑彬 董宗田)
上一页1 2 3